RxDx Assay fulfils an unmet medical need by helping clinicians identify patients with PTEN protein loss who may benefit from combination treatment with TRUQAP In prostate cancer, PTEN protein loss is ...

Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today the European Union In Vitro Diagnostic Regulation (IVDR) approval of ...

Roche gets EU IVDR approval for companion diagnostics panel across multiple cancer types and therapies: Tucson, Arizona Friday, June 12, 2026, 17:00 Hrs [IST] Roche has announced ...

Roche Holding received U.S. FDA Priority Review for Tecentriq plus chemotherapy as a potential adjuvant treatment for stage ...

Roche has signed a definitive merger agreement for the acquisition of US-based PathAI in a deal valued at up to $1.05bn. PathAI specialises in digital pathology and AI-powered diagnostics, serving ...

With global diabetes prevalence reaching an all-time high, the disease is taking a significant, often invisible toll on ...

Roche has introduced the first test based on a new technology – called TAGS – that it believes could revolutionise testing for infectious diseases by allowing high-throughput detection to be carried ...

According to financial terms announced Monday, Switzerland-based Roche will pay $24.05 cash for each GenMark share. That price represents a more than 30% premium to the company’s closing stock price ...

Roche Diagnostics has promoted Johnny Smith to global head of communications. Smith started in the role March 1. He reports to Barbara Schädler, head of group communications for Roche, which comprises ...

Roche has acquired Signature Diagnostics for an undisclosed price. The deal is designed to strengthen Roche’s cancer diagnostics effort with Signature’s expertise in both biobanks and next-generation ...

FRANKFURT, June 9 (Reuters) - The Swiss pharmaceutical and diagnostics giant Roche said it is sticking to its planned ...

Roche (RHHBY) said it will proceed with its planned €600M investment in a new diagnostics production facility in Penzberg, ...